Christopher M Blanchette

Summary

Affiliation: Lovelace Respiratory Research Institute
Country: USA

Publications

  1. doi request reprint Burden of blood transfusion in knee and hip surgery in the US and Belgium
    Christopher M Blanchette
    Lovelace Respiratory Research Institute, Albuquerque, NM, USA
    J Med Econ 12:171-9. 2009
  2. doi request reprint Health care use in depressed, elderly, cardiac patients and the effect of antidepressant use
    Christopher M Blanchette
    Center for Pharmacoeconomics and Outcomes Research, Lovelace Respiratory Research Institute, Kannapolis, NC 28081, USA
    Am J Health Syst Pharm 66:366-72. 2009
  3. doi request reprint Risk of hospitalizations/emergency department visits and treatment costs associated with initial maintenance therapy using fluticasone propionate 500 microg/salmeterol 50 microg compared with ipratropium for chronic obstructive pulmonary disease in older
    Christopher M Blanchette
    Center for Pharmacoeconomic and Outcomes Research, Lovelace Respiratory Research Institute, Albuquerque, New Mexico 87108, USA
    Am J Geriatr Pharmacother 6:138-46. 2008
  4. doi request reprint Advances in chronic obstructive pulmonary disease among older adults
    Christopher M Blanchette
    Lovelace Respiratory Research Institute, Kannapolis, NC, USA
    Curr Opin Pulm Med 17:84-9. 2011
  5. pmc Economic burden of chronic bronchitis in the United States: a retrospective case-control study
    Christopher M Blanchette
    Division of Clinical and Outcomes Research, Lovelace Respiratory Research Institute, Kannapolis, NC 28081, USA
    Int J Chron Obstruct Pulmon Dis 6:73-81. 2011
  6. doi request reprint Adherence to controller therapy for chronic obstructive pulmonary disease: a review
    Meaghan St Charles
    Lovelace Respiratory Research Institute, Kannapolis, North Carolina 28081, USA
    Curr Med Res Opin 26:2421-9. 2010
  7. ncbi request reprint Economic burden in direct costs of concomitant chronic obstructive pulmonary disease and asthma in a Medicare Advantage population
    Christopher M Blanchette
    Center for Pharmacoeconomic and Outcomes Research, Lovelace Respiratory Research Institute, 2425 Ridgecrest Dr SE, Albuquerque, NM 87108 5127, USA
    J Manag Care Pharm 14:176-85. 2008
  8. doi request reprint Association between previous health care use and initiation of inhaled corticosteroid and long-acting beta2-adrenergic agonist combination therapy among US patients with asthma
    Christopher M Blanchette
    Division of Clinical and Outcomes Research, Lovelace Respiratory Research Institute, Kannapolis, North Carolina 287081, USA
    Clin Ther 31:2574-83. 2009
  9. ncbi request reprint Comparison between spinal surgery blood transfusion services costs and associated treatment practices in the United States and Belgium
    Christopher M Blanchette
    Center for Pharmacoeconomic and Outcomes Research, Lovelace Respiratory Research Institute, Albuquerque, NM 87108, USA
    Curr Med Res Opin 23:2793-804. 2007
  10. doi request reprint Healthcare costs associated with initial maintenance therapy with fluticasone propionate 250 μg/salmeterol 50 μg combination versus anticholinergic bronchodilators in elderly US Medicare-eligible beneficiaries with COPD
    Anand A Dalal
    GlaxoSmithKline, Research Triangle Park, NC, USA
    J Med Econ 12:339-47. 2009

Detail Information

Publications30

  1. doi request reprint Burden of blood transfusion in knee and hip surgery in the US and Belgium
    Christopher M Blanchette
    Lovelace Respiratory Research Institute, Albuquerque, NM, USA
    J Med Econ 12:171-9. 2009
    ..The objective of this study was to assess treatments and costs associated with blood and blood product transfusions in a historical cohort of 189,457 inpatients in the US and 34,987 inpatients in Belgium undergoing knee or hip surgery...
  2. doi request reprint Health care use in depressed, elderly, cardiac patients and the effect of antidepressant use
    Christopher M Blanchette
    Center for Pharmacoeconomics and Outcomes Research, Lovelace Respiratory Research Institute, Kannapolis, NC 28081, USA
    Am J Health Syst Pharm 66:366-72. 2009
    ..The association between a diagnosis of depression after a thromboembolic event (TEE) and an increase in acute health care use was examined...
  3. doi request reprint Risk of hospitalizations/emergency department visits and treatment costs associated with initial maintenance therapy using fluticasone propionate 500 microg/salmeterol 50 microg compared with ipratropium for chronic obstructive pulmonary disease in older
    Christopher M Blanchette
    Center for Pharmacoeconomic and Outcomes Research, Lovelace Respiratory Research Institute, Albuquerque, New Mexico 87108, USA
    Am J Geriatr Pharmacother 6:138-46. 2008
    ..Cost-effective treatments for chronic obstructive pulmonary disease (COPD) are needed to reduce the burden on the Medicare system...
  4. doi request reprint Advances in chronic obstructive pulmonary disease among older adults
    Christopher M Blanchette
    Lovelace Respiratory Research Institute, Kannapolis, NC, USA
    Curr Opin Pulm Med 17:84-9. 2011
    ..This review summarizes recent research on chronic obstructive pulmonary disease (COPD) among older adults...
  5. pmc Economic burden of chronic bronchitis in the United States: a retrospective case-control study
    Christopher M Blanchette
    Division of Clinical and Outcomes Research, Lovelace Respiratory Research Institute, Kannapolis, NC 28081, USA
    Int J Chron Obstruct Pulmon Dis 6:73-81. 2011
    ..We examined how this later diagnosis may impact health care costs and utilization during the 12 months prior to and 24 months post initial CB diagnosis...
  6. doi request reprint Adherence to controller therapy for chronic obstructive pulmonary disease: a review
    Meaghan St Charles
    Lovelace Respiratory Research Institute, Kannapolis, North Carolina 28081, USA
    Curr Med Res Opin 26:2421-9. 2010
    ..The objective of this study was to review data on the outcomes of adherence to various controller therapies in patients with COPD in an effort to help prescribers understand adherence properties for each therapy...
  7. ncbi request reprint Economic burden in direct costs of concomitant chronic obstructive pulmonary disease and asthma in a Medicare Advantage population
    Christopher M Blanchette
    Center for Pharmacoeconomic and Outcomes Research, Lovelace Respiratory Research Institute, 2425 Ridgecrest Dr SE, Albuquerque, NM 87108 5127, USA
    J Manag Care Pharm 14:176-85. 2008
    ..The economic impact of concomitant asthma and COPD is potentially large but has not been studied...
  8. doi request reprint Association between previous health care use and initiation of inhaled corticosteroid and long-acting beta2-adrenergic agonist combination therapy among US patients with asthma
    Christopher M Blanchette
    Division of Clinical and Outcomes Research, Lovelace Respiratory Research Institute, Kannapolis, North Carolina 287081, USA
    Clin Ther 31:2574-83. 2009
    ....
  9. ncbi request reprint Comparison between spinal surgery blood transfusion services costs and associated treatment practices in the United States and Belgium
    Christopher M Blanchette
    Center for Pharmacoeconomic and Outcomes Research, Lovelace Respiratory Research Institute, Albuquerque, NM 87108, USA
    Curr Med Res Opin 23:2793-804. 2007
    ..This study assessed utilization and cost of allogeneic blood transfusion (ABT) associated with spinal surgery in the United States (US) and Belgium...
  10. doi request reprint Healthcare costs associated with initial maintenance therapy with fluticasone propionate 250 μg/salmeterol 50 μg combination versus anticholinergic bronchodilators in elderly US Medicare-eligible beneficiaries with COPD
    Anand A Dalal
    GlaxoSmithKline, Research Triangle Park, NC, USA
    J Med Econ 12:339-47. 2009
    ....
  11. ncbi request reprint Relationship between short-acting β2-adrenergic agonist use and healthcare costs
    Harris S Silver
    Division of Clinical and Outcomes Research, Lovelace Respiratory Research Institute, Kannapolis, NC 28081, USA
    Am J Manag Care 17:19-27. 2011
    ..To assess whether increased short-acting β(2)-adrenergic agonist (SABA) claims are associated with asthma exacerbations and increased healthcare costs...
  12. pmc Methylated Genes in Sputum Among Older Smokers With Asthma
    Akshay Sood
    Department of Medicine, University of New Mexico School of Medicine, NM, USA
    Chest 142:425-31. 2012
    ..The epigenetic basis for human asthma is not well studied, particularly among older adults. This study investigated the methylation profiles in sputum DNA among older adults with asthma, using a population of smokers...
  13. doi request reprint Cost and utilization of COPD and asthma among insured adults in the US
    Christopher M Blanchette
    Center for Pharmacoeconomics and Outcomes Research, Lovelace Respiratory Research Institute, Albuquerque, NM 87108, USA
    Curr Med Res Opin 25:1385-92. 2009
    ..This study evaluates the burden of concomitant chronic obstructive pulmonary disease (COPD) + asthma, two highly prevalent and costly conditions...
  14. pmc Severity of COPD at initial spirometry-confirmed diagnosis: data from medical charts and administrative claims
    Douglas W Mapel
    Lovelace Clinic Foundation, Albuquerque, NM 87106, USA
    Int J Chron Obstruct Pulmon Dis 6:573-81. 2011
    ..This study was conducted to determine COPD severity at the time of diagnosis as confirmed by spirometry in patients treated in a US managed care setting...
  15. doi request reprint The role of combination inhaled corticosteroid/long-acting beta-agonist therapy in COPD management
    Douglas W Mapel
    Lovelace Clinic Foundation, Albuquerque, New Mexico 87106, USA
    Prim Care Respir J 19:93-103. 2010
    ..This review focuses on the role of combination ICS/LABA therapy in managing COPD, including indications, potential benefits and considerations that affect therapy decisions...
  16. doi request reprint Quarterly assessment of short-acting beta(2)-adrenergic agonist use as a predictor of subsequent health care use for asthmatic patients in the United States
    Harris S Silver
    Division of Clinical and Outcomes Research, Lovelace Respiratory Research Institute, Albuquerque, New Mexico, USA
    J Asthma 47:660-6. 2010
    ..The purpose of this study was to determine whether excessive short-acting beta(2)-adrenergic agonist (SABA) dispensed quarterly was associated with asthma exacerbations in the subsequent quarter...
  17. pmc Cost-effectiveness of combination fluticasone propionate-salmeterol 250/50 microg versus salmeterol in severe COPD patients
    Anand A Dalal
    US Health Outcomes, GlaxoSmithKline, Research Triangle Park, NC, USA
    Int J Chron Obstruct Pulmon Dis 5:179-87. 2010
    ..To estimate the cost-effectiveness of fluticasone propionate-salmeterol combination (FSC) compared to salmeterol for maintenance therapy in severe chronic obstructive pulmonary disease (COPD)...
  18. doi request reprint A secondary analysis of a duration response association between selective serotonin reuptake inhibitor use and the risk of acute myocardial infarction in the aging population
    Christopher M Blanchette
    Center for Pharmacoeconomic and Outcomes Research, Lovelace Respiratory Research Institute, Albuquerque, NM 87108, USA
    Ann Epidemiol 18:316-21. 2008
    ..We assessed the risk of selective serotonin reuptake inhibitor (SSRI) use on the occurrence of acute myocardial infarction (AMI) based on duration of exposure...
  19. ncbi request reprint Resource utilization and costs of blood management services associated with knee and hip surgeries in US hospitals
    Christopher M Blanchette
    Premier, Inc Charlotte, NC, USA
    Adv Ther 23:54-67. 2006
    ..30; 95% CI, 2.06-2.57) had a greater likelihood of ABT. Investigators concluded that most transfusion reduction techniques are underused, or they do not reduce the burden of ABT associated with knee or hip surgery...
  20. doi request reprint Economic burden prior to COPD diagnosis: a matched case-control study in the United States
    Manabu Akazawa
    Department of Health Policy and Administration, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
    Respir Med 102:1744-52. 2008
    ..To understand the economic burden of COPD prior to diagnosis in the U.S., trends in utilization and costs during the period before initial COPD diagnosis were compared with matched controls...
  21. pmc Depression following thrombotic cardiovascular events in elderly medicare beneficiaries: risk of morbidity and mortality
    Christopher M Blanchette
    Division of Clinical and Outcomes Research, Lovelace Respiratory Research Institute, Albuquerque, NM 87108, USA
    Cardiol Res Pract 2009:194528. 2009
    ..Conclusions. Depression was not associated with time to death or recurrent TCEs in this study. Antidepressant use, including measures of any antidepressant use and SSRI use, was not associated with shorter time to death or recurrent TCE...
  22. pmc Wood smoke exposure and gene promoter methylation are associated with increased risk for COPD in smokers
    Akshay Sood
    University of New Mexico School of Medicine, Albuquerque, New Mexico, USA
    Am J Respir Crit Care Med 182:1098-104. 2010
    ..Wood smoke-associated chronic obstructive pulmonary disease (COPD) is common in women in developing countries but has not been adequately described in developed countries...
  23. pmc Cost and utilization of blood transfusion associated with spinal surgeries in the United States
    Christopher M Blanchette
    Premier Inc, Pharmaceutical Research Services, Charlotte, NC, USA
    Eur Spine J 16:353-63. 2007
    ..Patients that received cell salvage had a lower risk of transfusion (OR=0.40; 95% CI, 0.32-0.50). Most blood avoidance techniques have low utilization or do not reduce the burden of transfusion associated with spinal fusion...
  24. doi request reprint Changes in COPD demographics and costs over 20 years
    Christopher M Blanchette
    Department of Public Health Sciences, University of North Carolina, Charlotte, NC 28223, USA
    J Med Econ 15:1176-82. 2012
    ..The purpose of this study was to examine the changes in COPD costs over 20 years and assess total direct cost trends over the last 10...
  25. ncbi request reprint Economic assessment of initial maintenance therapy for chronic obstructive pulmonary disease
    Manabu Akazawa
    Department of Health Policy and Administration, University of North Carolina at Chapel Hill, USA
    Am J Manag Care 14:438-48. 2008
    ....
  26. doi request reprint Burden of concomitant asthma and COPD in a Medicaid population
    Fadia T Shaya
    Pharmaceutical Health Services Research Department, University of Maryland School of Pharmacy, 220 Arch St, Twelfth Floor, Baltimore, MD 21201, USA
    Chest 134:14-9. 2008
    ..This study compares utilization outcomes in patients with asthma, COPD, or co-occurring asthma and COPD in a Medicaid population, and assesses the incremental burden of COPD in patients with asthma...
  27. ncbi request reprint Influence of medication treatment patterns on resource use for patients hospitalized for schizophrenia
    David R Strutton
    Global Health Outcomes Assessment, Wyeth Research, Collegeville, PA, USA
    Am J Health Syst Pharm 65:42-8. 2008
    ..The influence of medication treatment patterns on resource use for patients hospitalized for schizophrenia was studied...
  28. ncbi request reprint Comparison of hospitalizations, emergency department visits, and costs in a historical cohort of Texas Medicaid patients with chronic obstructive pulmonary disease, by initial medication regimen
    Karen L Rascati
    College of Pharmacy and the Center for Pharmacoeconomic Studies, University of Texas at Austin, Austin, Texas 78712 0127, USA
    Clin Ther 29:1203-13. 2007
    ..Limited information is available on the relative outcomes and treatment costs of various pharmacotherapies for chronic obstructive pulmonary disease (COPD) in a Medicaid population...
  29. pmc Drug use patterns in severely mentally ill Medicare beneficiaries: impact of discontinuities in drug coverage
    Linda Simoni-Wastila
    Peter Lamy Center on Drug Therapy and Aging, University of Maryland Baltimore School of Pharmacy, 220 Arch Street, 12th Floor, Baltimore, MD 21201, USA
    Health Serv Res 43:496-514. 2008
    ....
  30. ncbi request reprint Selective cyclooxygenase-2 inhibition and cardiovascular effects: an observational study of a Medicaid population
    Fadia T Shaya
    Department of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, Baltimore, MD 21201, USA
    Arch Intern Med 165:181-6. 2005
    ..This observational cohort study examines the cardiovascular risk of COX-2 inhibitors compared with nonspecific NSAIDs in Maryland Medicaid enrollees, a high-risk population...